0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Gut & Microbiome Human Health Effects Sign in to save

Polystyrene microplastics exposure: Disruption of intestinal barrier integrity and hepatic function in infant mice

Ecotoxicology and Environmental Safety 2024 8 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Huan Li, Shimin Xu, Feng Zhou, Su Liu, Dong Zhang, Dong Zhang, Xuanyi Wei

Summary

Researchers found that even low concentrations of polystyrene microplastics caused significant gut barrier damage and liver injury in infant mice. The microplastics disrupted the intestinal lining, allowed particles to leak into the bloodstream, and triggered liver fat accumulation and altered gut bacteria colonization. The study raises concerns about microplastic exposure during early life, when developing digestive and liver systems may be especially vulnerable.

Polymers
Body Systems
Models
Study Type In vivo

The pervasive presence of microplastics (MPs) in infant formula and care products has emerged as a significant and underappreciated risk to public health. Notably, infants are at an elevated risk due to their underdeveloped intestinal defenses and liver detoxification capabilities, factors that could heighten their vulnerability to MPs. This study presents a comprehensive evaluation of the health implications linked to polystyrene microplastics (PSMPs) exposure during early life, examining both environmentally plausible and elevated levels. Based on histological analysis, in vivo imaging analysis, biochemical analysis and 16S rRNA sequencing results, our study found that oral PSMPs exposure in infant mice led to profound toxicological consequences, such as intestinal barrier impairment and hepatic injury, in a dose-dependent manner. Strikingly, even low ambient concentration of PSMPs (20 ppb) was sufficient to inflict considerable harm, disrupting the intestinal barrier, manifested that lessened mucus secretion, elevated iFABP level (276.50±10.73 pg/mL), decreased sIgA levels (0.60±0.03 mg/g), and pathological damage of intestinal tissues, allowing PSMPs accumulation and leakage into blood, inducing hepatotoxicity, such as increased TG levels (0.99±0.05 mmol/gprot) and lipid droplet accumulation. Furthermore, PSMPs exposure gives rise to aberrant bacterial colonization, dropping the abundance of probiotics as well as altering the abundance of pathogenic bacteria, which may contribute to the toxicity outcomes. The study underscores the critical need for vigilance regarding the insidious effects of PSMPs at environmental-relevant concentrations, especially in the context of infant exposure.

Share this paper